What is the washout period in Oral Contraceptive Pills (OCP) pre-treatment for In Vitro Fertilization (IVF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

OCP Washout Period in IVF Pre-treatment

The recommended washout period after OCP pre-treatment in IVF is 5 days before starting ovarian stimulation with GnRH antagonist protocols. 1, 2

Standard Washout Protocol

  • Start gonadotropin stimulation 5 days after stopping OCPs in GnRH antagonist IVF cycles 1, 2
  • This 5-day interval allows for adequate clearance of exogenous hormones while maintaining follicular synchronization 1
  • The washout period is critical because FSH suppression from OCPs can persist for 5-7 days after discontinuation 2

Evidence Supporting the 5-Day Washout

  • A large retrospective study of 4,116 patients demonstrated that using a 5-day washout period after 12-30 days of OCP treatment resulted in comparable live birth rates (32.4%) and cumulative live birth rates to non-OCP cycles 1
  • Multiple randomized controlled trials have consistently used and validated the 5-day washout interval, showing no detrimental effects on oocyte yield, embryo quality, or pregnancy outcomes 2, 3

Alternative Washout Considerations

Some protocols have explored a 6-day washout period when comparing OCPs to estradiol valerate pre-treatment, though this appears to offer no additional benefit over the standard 5-day interval 2

Duration of OCP Pre-treatment

  • OCPs are typically administered for 12-30 days before the washout period begins 1
  • Shorter durations (12-16 days) are commonly used and appear equally effective as longer courses 3
  • The OCP formulations studied include ethinyl estradiol 30 μg with either desogestrel 150 μg or levonorgestrel 150 μg 1, 2, 3

Clinical Outcomes with Standard Washout

  • No negative impact on live birth rates when using the 5-day washout protocol 1
  • No differences in oocyte maturity, embryo quality, or implantation rates compared to cycles without OCP pre-treatment 1, 4
  • The number of oocytes retrieved may be slightly higher with OCP pre-treatment (adjusted β 0.22,95% CI 0.12-0.31), though this does not translate to improved pregnancy outcomes 1

Special Population: PCOS Patients

  • In women with PCOS undergoing IVF, a 7-day washout period after OCP pre-treatment has been studied, with ovarian stimulation starting on Day 7 of the washout 4
  • This approach resulted in non-inferior embryo quality and comparable live birth rates (78.3% cumulative) to immediate stimulation without OCP pre-treatment 4
  • The rationale for OCP pre-treatment in PCOS (lowering LH levels) may not provide additional benefit, as embryo quality and pregnancy outcomes are similar with or without OCPs 4

Common Pitfalls to Avoid

  • Do not start stimulation immediately after stopping OCPs without the appropriate washout period, as residual FSH suppression may impair follicular recruitment 2
  • Avoid excessively long washout periods (>7 days), as this provides no additional benefit and only delays treatment 1, 2
  • Do not assume longer OCP pre-treatment duration improves outcomes—12-16 days is sufficient and comparable to longer courses 3

Practical Implementation

  • Stop OCPs after 12-30 days of administration 1
  • Wait exactly 5 days (standard) or up to 7 days (in PCOS) 1, 4
  • Begin recombinant FSH on the designated day regardless of bleeding pattern 4
  • Use GnRH antagonist protocol as planned with no modifications needed for the washout period 1, 2, 3

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.